- Vycor Medical (OTCQB:VYCO): FY GAAP EPS of -$0.08.
- Revenue of $1.51M (+9.4% Y/Y)
- Press Release
- More news on: Vycor Medical, Inc., Earnings news and commentary, Healthcare stocks news, ,
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
BOCA RATON, FL, June 30, 2020 (GLOBE NEWSWIRE) -- Vycor Medical, Inc. (“Vycor”) (OTCBB—VYCO) today announced that its wholly owned subsidiary, NovaVision, Inc. (“NovaVision”), has signed an agreement in principle to enter into an exclusive licensing agre...
BOCA RATON, FL, March 27, 2020 (GLOBE NEWSWIRE) -- Vycor Medical, Inc. (Vycor) (OTCQB: VYCO), a provider of innovative and superior surgical and therapeutic solutions, reported financial results for the year ended December 31, 2019. Highlights The Vycor Medical division recorded r...
BOCA RATON, FL, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Vycor Medical, Inc. (OTCQB: VYCO) Jose Romano, Chief of the Stroke Division at the University of Miami Miller School of Medicine, co-authored a recently published international study that shows that visual rehabilitation is effective ...